Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Immune Cell Function and Interaction

41 ta ish

  1. IMMUNOTHERAPEUTIC SIGNIFICANCE OF NTPASE 8 IN ONCOLOGY

    Ibrohimjon Rahmonovich Asqarov, Irodakhonv Mamatova, Mohinur A. Tadjibaeva

    MaqolaAdenosine and Purinergic SignalingJournal of Chemistry of Goods and Traditional Medicine20250 iqtibos
    ABI

  2. The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders

    Farag M. A. Altalbawy, Zarrina Babamuradova, Lalji Baldaniya +7

    Sharh maqolaImmune Cell Function and InteractionExperimental Cell Research20250 iqtibos
    ABI

  3. New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK

    Saade Abdalkareem Jasim, Harikumar Pallathadka, G. V. Sivaprasad +7

    Sharh maqolaCAR-T cell therapy researchFunctional & Integrative Genomics20250 iqtibos
    ABI

  4. Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies

    Omer Qutaiba B. Allela, Ali Fawzi Al-Hussainy, Gaurav Sanghvi +9

    Sharh maqolaCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 iqtibos
    ABI

  5. SLAMF8 (BLAME) as a novel immune checkpoint: Implications for inflammation, autoimmunity, and oncology

    Ahmed Husseni, Farag M. A. Altalbawy, Irwanjot Kaur +7

    Sharh maqolaImmune Cell Function and InteractionPathology - Research and Practice20250 iqtibos
    ABI

  6. Exploring SLAMF5/CD84 in Cancer: Advancing the Frontiers of Tumor Immunology

    Safia Obaidur Rab, Ahmed Hussein Zwamel, Ashok Kumar Bishoyi +6

    Sharh maqolaImmune Cell Function and InteractionCell Biology International20250 iqtibos
    ABI

  7. <i>Staphylococcus aureus</i> Sb‐1 Bacteriophage Alters Frequency and Subset Distribution of Human Innate Lymphoid Cells

    Ramazan J. Rozumbetov, İsmail Öğülür, Anja Heider +12

    MaqolaBacteriophages and microbial interactionsAllergy20260 iqtibos
    ABI

  8. Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

    Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

    MaqolaCAR-T cell therapy researchDiscover Oncology20260 iqtibos
    ABI

  9. Bispecific and multispecific immune engagers for redirecting innate and adaptive immunity against hematologic cancers

    Mustafa T. Ardah, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

    MaqolaMonoclonal and Polyclonal Antibodies ResearchDiscover Oncology20260 iqtibos
    ABI

  10. Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers

    Ghaleb Oriquat, Waleed K. Abdulsahib, Sajida Hussein Ismael +6

    MaqolaImmune Cell Function and InteractionAnnals of Hematology20260 iqtibos
    ABI

  11. SLAMF1 at the crossroads of immunity and disease: Biology, pathology, and therapeutic opportunities

    Irfan Ahmad, Farag M.A. Altalbawy, Ashok Kumar Bishoyi +7

    MaqolaImmune Cell Function and InteractionCytokine20260 iqtibos
    ABI

  12. CAR‐NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer

    Xiao Lyu, Na Zhu, Ruijuan Guo +1

    MaqolaCAR-T cell therapy researchCell Biology International20260 iqtibos
    ABI

  13. OITS KASALLIGI IMMUNITETGA TA'SIRI. HUMAN IMMUNODEFICIENCY VIRUSI IMMUN TIZIMINI ZARARLASH MEXANIZMI

    Abduvositova Gavharoy Burxoniddin qizi, Moydinova Nurxon Mirzayevna

    MaqolaViral Infections and Immunology ResearchZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  14. OITS KASALLIGI IMMUNITETGA TA'SIRI. HUMAN IMMUNODEFICIENCY VIRUSI IMMUN TIZIMINI ZARARLASH MEXANIZMI

    Abduvositova Gavharoy Burxoniddin qizi, Moydinova Nurxon Mirzayevna

    MaqolaViral Infections and Immunology ResearchZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  15. IMMUN TIZIM VA KO'KRAK BEZI SARATONI O'RTASIDAGI BOG'LIQLIK

    Zebo Xudoyqulova, Ogʻabek Abdurahimov, Aslbek Kucharov +3

    MaqolaImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  16. IMMUN TIZIM VA KO'KRAK BEZI SARATONI O'RTASIDAGI BOG'LIQLIK

    Zebo Xudoyqulova, Ogʻabek Abdurahimov, Aslbek Kucharov +3

    MaqolaImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI